Using animal models, experimental cells, and human samples of AH and alcoholic cirrhosis, investigators conjunctively found that the reversal of hepatocyte defects mediated by YAP inhibition appears to be a therapeutic strategy for AH regenerative treatment. This evidence concerns the gene YAP1 and alcoholic liver cirrhosis.